|
|
Director/PDMR Shareholding |
Download |
|
|
Share Purchase Agreement Signed - Sale of Lyramid |
Download |
|
|
Proposed Sale of Midkine Portfolio |
Download |
|
|
Director Share Distribution |
Download |
|
|
Conversion of Convertible Loan Notes |
Download |
|
|
STAT-6 siRNA Presentation |
Download |
|
|
Interim Results to 30 June 2024 |
Download |
|
|
Grant of Japan MK Cell Patent |
Download |
|
|
STAT-6 siRNA Demonstrates Efficacy in Immunology |
Download |
|
|
Grant of MK Cell Patent & Licencing Update |
Download |
|
|
Results of AGM |
Download |
|
|
Appointment of Broker |
Download |
|
|
Notice of Annual General Meeting |
Download |
|
|
Issue of Convertible Loan Notes & Board Changes |
Download |
|
|
Midkine Antibody Licencing Deal |
Download |
|
|
Annual Report & Financial Statements - 31 Dec 2023 |
Download |
|
|
Response to Share Price Movement |
Download |
|
|
Positive Results: Midkine mRNA and STAT-6 siRNA |
Download |
|
|
Operations Update |
Download |
|
|
Change of Auditor |
Download |
|
|
Significant Mesodermal Killer Cell Milestone |
Download |
|
|
Interim Results to 30 June 2023 |
Download |
|
|
Investor Presentation via Investor Meet Company |
Download |
|
|
Expansion of Patent Portfolio |
Download |
|
|
Development of New Novel siRNA Therapeutics |
Download |
|
|
Director/PDMR Shareholding |
Download |
|
|
Director/PDMR Shareholding |
Download |
|
|
Results of AGM |
Download |
|
|
AGM Statement |
Download |
|
|
Investor Presentation via Investor Meet Company |
Download |
|
|
Director/PDMR Shareholding |
Download |
|
|
Director/PDMR Shareholding |
Download |
|
|
Director/PDMR Shareholding |
Download |
|
|
RNA Medicine Shows In Vitro Anti-Cancer Efficacy |
Download |
|
|
Antibody Program Results & Orphan Drug Indication |
Download |
|
|
Anti-Cancer MDK mRNA - Positive in vitro Results |
Download |
|
|
Restoration of Trading |
Download |
|
|
Notice of Annual General Meeting |
Download |
|
|
Annual Report & Financial Statements - 31 Dec 2022 |
Download |
|
|
Suspension of Trading Pending 2022 Annual Report |
Download |
|
|
Suspension - Roquefort Therapeutics plc |
Download |
|
|
Confirmation of No Exposure to Silicon Valley Bank |
Download |
|
|
Creation of New Novel Family of mRNA Therapeutics |
Download |
|
|
Formation of Scientific Advisory Board |
Download |
|
|
Company Presentation |
Download |
|
|
Investor Presentation |
Download |
|
|
Randox Licence and Royalty Agreement |
Download |
|
|
MDK Oncology Antibodies Demonstrate In-Vivo Safety |
Download |
|
|
Holding(s) in Company |
Download |
|
|
Appointment of Auditor |
Download |